These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1386207)

  • 1. Neuropathologic features of Parkinson's, Huntington's, and Alzheimer's diseases.
    Forno LS
    Ann N Y Acad Sci; 1992 May; 648():6-16. PubMed ID: 1386207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The co-occurrence of Alzheimer's disease and Huntington's disease: a neuropathological study of 15 elderly Huntington's disease subjects.
    Davis MY; Keene CD; Jayadev S; Bird T
    J Huntingtons Dis; 2014; 3(2):209-17. PubMed ID: 25062863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Reactive Oxygen Species in the Pathogenesis of Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease: A Mini Review.
    Manoharan S; Guillemin GJ; Abiramasundari RS; Essa MM; Akbar M; Akbar MD
    Oxid Med Cell Longev; 2016; 2016():8590578. PubMed ID: 28116038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders.
    Whitehouse PJ; Kellar KJ
    J Neural Transm Suppl; 1987; 24():175-82. PubMed ID: 2960781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
    Mantle D; Falkous G; Ishiura S; Perry RH; Perry EK
    J Neurol Sci; 1995 Jul; 131(1):65-70. PubMed ID: 7561949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of neurodegenerative diseases.
    Ribeiro FM; Camargos ER; de Souza LC; Teixeira AL
    Braz J Psychiatry; 2013; 35 Suppl 2():S82-91. PubMed ID: 24271230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemical studies of substance P and Met-enkephalin in the basal ganglia and substantia nigra in Huntington's, Parkinson's and Alzheimer's diseases.
    Grafe MR; Forno LS; Eng LF
    J Neuropathol Exp Neurol; 1985 Jan; 44(1):47-59. PubMed ID: 2578185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Alzheimer's Disease Neuropathologic Changes with Clinical Presentations of Parkinson's Disease.
    Tong Q; Chen L
    J Alzheimers Dis; 2021; 81(1):201-207. PubMed ID: 33720903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
    Clark LF; Kodadek T
    ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic animal models of neurodegeneration based on human genetic studies.
    Harvey BK; Richie CT; Hoffer BJ; Airavaara M
    J Neural Transm (Vienna); 2011 Jan; 118(1):27-45. PubMed ID: 20931247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dementia of the Alzheimer's type and Huntington's disease.
    Reyes MG; Gibbons S
    Neurology; 1985 Feb; 35(2):273-7. PubMed ID: 3155827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol metabolism and homeostasis in the brain.
    Zhang J; Liu Q
    Protein Cell; 2015 Apr; 6(4):254-64. PubMed ID: 25682154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Mitochondrial Complex II and III Activity in Brain Sections: A Histoenzymological Technique.
    Roy R; Paul R; Bhattacharya P; Borah A
    Methods Mol Biol; 2022; 2497():73-81. PubMed ID: 35771435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
    Beal MF
    Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients.
    Ditter SM; Mirra SS
    Neurology; 1987 May; 37(5):754-60. PubMed ID: 3033544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IX. A prospective cliniconeuropathologic study of Parkinson's features in Alzheimer's disease.
    Hulette C; Mirra S; Wilkinson W; Heyman A; Fillenbaum G; Clark C
    Neurology; 1995 Nov; 45(11):1991-5. PubMed ID: 7501147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
    Hroudová J; Singh N; Fišar Z
    Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dementia in movement disorders.
    Teräväinen H; Hietanen M; Stoessl J; Calne DB
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):546-58. PubMed ID: 2947669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of molecular chaperone in protein-misfolding brain diseases.
    Wankhede NL; Kale MB; Upaganlawar AB; Taksande BG; Umekar MJ; Behl T; Abdellatif AAH; Bhaskaran PM; Dachani SR; Sehgal A; Singh S; Sharma N; Makeen HA; Albratty M; Dailah HG; Bhatia S; Al-Harrasi A; Bungau S
    Biomed Pharmacother; 2022 Mar; 147():112647. PubMed ID: 35149361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurolinguistic features of spontaneous language production dissociate three forms of neurodegenerative disease: Alzheimer's, Huntington's, and Parkinson's.
    Illes J
    Brain Lang; 1989 Nov; 37(4):628-42. PubMed ID: 2479447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.